Clinical Trial Update: Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing methylprednisolone to dexamethasone in COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome
• Viral Pneumonia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: University of Trieste | Conditions: Covid19, Viral Pneumonia Human Coronavirus | Phase 3 | Status: COMPLETED